Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 2
2002 2
2003 3
2004 3
2005 11
2006 5
2007 3
2008 5
2009 6
2010 5
2011 3
2012 4
2013 2
2014 4
2015 6
2016 5
2017 8
2018 1
2019 2
2020 5
2021 4
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy.
Hutka B, Várallyay A, László SB, Tóth AS, Scheich B, Paku S, Vörös I, Pós Z, Varga ZV, Norman DD, Balogh A, Benyó Z, Tigyi G, Gyires K, Zádori ZS. Hutka B, et al. Among authors: paku s. Acta Pharmacol Sin. 2024 Feb;45(2):339-353. doi: 10.1038/s41401-023-01175-7. Epub 2023 Oct 10. Acta Pharmacol Sin. 2024. PMID: 37816857 Free PMC article.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Grusch M, Laszlo V, Dome B, Schelch K. Valko Z, et al. Among authors: paku s. Br J Cancer. 2023 May;128(10):1850-1861. doi: 10.1038/s41416-023-02219-9. Epub 2023 Mar 14. Br J Cancer. 2023. PMID: 36918717 Free PMC article.
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B, Megyesfalvi Z, Woldmar N, Valkó Z, Schwendenwein A, Bárány N, Paku S, László V, Kiss H, Bugyik E, Lang C, Szász AM, Pizzatti L, Bogos K, Hoda MA, Hoetzenecker K, Marko-Varga G, Horvatovich P, Döme B, Schelch K, Rezeli M. Szeitz B, et al. Among authors: paku s. Clin Transl Med. 2022 Sep;12(9):e1060. doi: 10.1002/ctm2.1060. Clin Transl Med. 2022. PMID: 36149789 Free PMC article.
Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow.
Kovacs I, Bugyik E, Dezso K, Tarnoki-Zach J, Mehes E, Gulyas M, Czirok A, Lang E, Grusch M, Schelch K, Hegedus B, Horvath I, Barany N, Megyesfalvi Z, Tisza A, Lohinai Z, Hoda MA, Hoetzenecker K, Pezzella F, Paku S, Laszlo V, Dome B. Kovacs I, et al. Among authors: paku s. Transl Lung Cancer Res. 2022 Jun;11(6):991-1008. doi: 10.21037/tlcr-21-828. Transl Lung Cancer Res. 2022. PMID: 35832452 Free PMC article.
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B. Megyesfalvi Z, et al. Among authors: paku s. J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25. J Pathol. 2022. PMID: 35489038 Free PMC article.
[Heterogeneity of small cell lung cancer: biological and clinicopathological implications].
Megyesfalvi Z, Bárány N, Valkó Z, Bugyik E, Paku S, Berta J, Lantos A, Fillinger J, Moldvay J, Bogos K, Rezeli M, Gálffy G, Lang C, Lohinai Z, Hécz R, Lovas T, Rényi-Vámos F, László V, Döme B. Megyesfalvi Z, et al. Among authors: paku s. Magy Onkol. 2020 Sep 23;64(3):243-255. Epub 2020 Aug 9. Magy Onkol. 2020. PMID: 34608895 Free article. Hungarian.
Clinical relevance of circulating activin A and follistatin in small cell lung cancer.
Barany N, Rozsas A, Megyesfalvi Z, Grusch M, Hegedus B, Lang C, Boettiger K, Schwendenwein A, Tisza A, Renyi-Vamos F, Schelch K, Hoetzenecker K, Hoda MA, Paku S, Laszlo V, Dome B. Barany N, et al. Among authors: paku s. Lung Cancer. 2021 Nov;161:128-135. doi: 10.1016/j.lungcan.2021.09.008. Epub 2021 Sep 20. Lung Cancer. 2021. PMID: 34583221 Free article.
Molecular profiles of small cell lung cancer subtypes: therapeutic implications.
Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, Rezeli M, Marko-Varga G, Bogos K, Galffy G, Renyi-Vamos F, Hoda MA, Klepetko W, Hoetzenecker K, Laszlo V, Dome B. Schwendenwein A, et al. Among authors: paku s. Mol Ther Oncolytics. 2021 Feb 6;20:470-483. doi: 10.1016/j.omto.2021.02.004. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33718595 Free PMC article. Review.
88 results